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Abstract
Background: Patients with chronic depression (persisting symptoms for ≥2 years) are a clinically relevant group
with extensive (co)morbidity, high functional impairment and associated costs in primary care. The General
Practitioner (GP) is the main health professional attending to these patients. The aim of this study was to examine
the GPs’ perception on managing patients with chronic depression.
Methods: We performed an explorative cross-sectional study with a systematic sample of GPs in central Germany.
Source of data was a written questionnaire (46 items). Descriptive analysis was carried out.
Results: Two hundred twenty (out of 1000; 22%) GPs participated. 93% of the GPs distinguish between care for
patients with chronic depression and acute depressive episode. 92% would recommend psychotherapeutic
co-treatment to the chronically depressed patient. 52% of GPs would favour a general restraint on antidepressants
(ADs) in older chronically depressed patients (≥ 75 years) whereas 40% suggest long-term pharmacotherapy. If severe
physical comorbidity is present GPs would be restrictive in prescribing ADs (65%) or would urgently refer to specialist
psychiatric services (40%). In case of a comorbid anxiety disorder 66% of the GPs would suggest a combined psycho- und
pharmacotherapy. If a substance use disorder coexists 84% would prefer urgent referrals to specialist services.
Conclusions: Participating GPs report awareness towards chronic depression in their patients. Physical and mental
comorbidity seem to play an important role in GPs’ treatment decisions.
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Background
In primary care 10–30% of patients with major depres-
sive disorder develop a chronic course with persistent
symptoms of at least 2 years [1, 2]. Patients with chronic
depression show higher rates of physical and mental co-
morbidity as well as more severe and longer lasting
functional and psychosocial impairment than individuals
with acute episodic depression [3–5]. Consequently,
GPs, who are the main health professionals attending to
these patients, face severe challenges [6, 7]. There is
evidence that due to the specific characteristics, needs
and treatment options for this patient group the clinical
differentiation between chronic and acute depressive
episode is both meaningful and useful [2, 3, 5, 8–10].
Guideline recommendations are predominantly
directed to acute forms of depression due to the unsatis-
fying evidence base for the treatment of chronic courses
[11]. Pharmacological and psychotherapeutic treatment
of chronically depressed patients is recommended by
several clinical practice guidelines including the
American Psychiatric Association (APA), the National
Institute for Health and Clinical Excellence (NICE) and
the German National Disease Management Guidelines
(NDMG). Regardless of chronicity antidepressant
continuation for at least 24 weeks (APA and NDMG: 4–
9 months) is suggested after a successful acute phase
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[11–13]. Frequent consultations and constant monitor-
ing (evaluation of response, treatment efficacy and toler-
ability, measures of blood count and liver enzymes, ECG
controls) are further required throughout the process of
AD treatment [11]. Risk factors supporting a long term
(2 years to lifetime) AD maintenance therapy are
amongst others older age, chronic episodes and signifi-
cant mental or physical comorbidity [14]. NICE suggests
a maintenance treatment in elderly patients with mul-
tiple depressive episodes in order to prevent relapse [13].
Since there are only a few studies performed in primary
care settings with follow-up periods longer than 12 weeks
and satisfactory sample sizes, appropriate analysis of
long-term AD and/or psychotherapeutic effects is cur-
rently not possible [15–19].
Evidence for treatment of chronically depressed pa-
tients with comorbidity is still limited [20]. Patient-
related factors such as old age, severe physical or mental
comorbidity are common in primary care patients and
may have impact on GPs’ therapeutic decision-making
and outcome [21–24]. However, guideline recommenda-
tions are mainly based on studies with highly selected
patients not complicated by mental and physical comor-
bidities or social difficulties [25].
Since most treatment recommendations for chronic
depression derive from patients in specialist care re-
search is needed to analyse the health care delivery for
chronic depression in primary care settings [2, 5].
Objectives
Main objective: To examine if German GPs distinguish
between patients with chronic and acute episodic
depression.
Further objectives: To describe the GPs’ self-reported
management of patients with chronic depression and to
investigate the association between age, physical or men-
tal comorbidity and GPs’ treatment decisions.
Methods
An explorative cross sectional survey was performed in
central Germany from June to August 2015. Expecting a
response rate of at least 20% to 30% as obtained in our
prior surveys we contacted 1000 German GPs, who were
randomly chosen from a database provided by the Asso-
ciation of Statutory Health Insurance Physicians in the
federal states of Thuringia and Bavaria. In each case 500
GPs were contacted representing 30% of all Thuringian
and 5.5% of all Bavarian GPs. They were asked to
complete a written questionnaire anonymously.
The questionnaire was designed and piloted (n = 5
GPs) consisting of 46 items. Ten items referred to GPs’
characteristics and 36 items dealt with their manage-
ment of chronically depressed patients:
 two items covered diagnostic measures (use of
validated instruments, screening for comorbidity)
[11]
 eleven items dealt with pharmacotherapy (initiation,
duration, selection of active agent, switching)
[11–14, 20]
 two items approached the therapeutic differences
between chronic and acute episodic depression
[5, 9, 10, 26]
 seven items asked for the use of additional non-
medical approaches (e.g. psychoeducation, frequency
of consultations, monitoring, adherence enhance-
ment, crisis management) [11]
 three items concerned the co-treatment by special-
ists (motives for referral, waiting times, availability)
[11, 27]
 seven items addressed patient related-factors rele-
vant for clinical decision making (e.g. advanced age,
severe physical or mental comorbidity)
[11, 13, 14, 28]
 four items were constructed to estimate the
influence of other factors (work incapacity, guideline
recommendations, clinical experience, billing and
reimbursement) [29, 30]
Since the German National Disease Management
Guideline (NDMG) for unipolar depression contains
hardly any recommendations for the management of
chronic depression, our questionnaire was not aimed to
test GPs’ guideline concordance. Nevertheless many of the
constructed items were based upon NDMG recommenda-
tions for unipolar depression in order to provide a vast
spectrum of procedures which have been clinically proven
and are based on the best evidence available [11]. A brief
case report (68 words) of a chronically depressed patient
was introduced in order to homogenate the understanding
of the subsequent questions to GPs on their management
of chronically depressed patients. Based on prevailing sci-
entific doctrine we provided a definition of chronic course
in terms of persisting symptoms for ≥2 years [2, 5, 8, 11].
The central question was if GPs differentiate between
chronic and acute episodic depression. Most items
including the main question were formulated as closed
statements, which could be agreed or disagreed, others
were constructed as ratings and participants had to
estimate the specific degree of relevance. Answering the
questionnaire took about 15 min based on the pilot test.
Logical missings were defined in advance.
Data analysis
Data were transcribed electronically into a database. We
performed a descriptive analysis of quantitative variables
using SPSS Statistics. Chi-square test was used to exam-
ine GPs’ differentiation between chronic and acute
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depressive episode. Other characteristics were displayed
through absolute and relative frequencies. Explorative
subgroup analyses (paired comparison) were conducted
based on participating GPs’ characteristics (see Table 1).
Incomplete data was addressed by performing imput-
ation variance estimation with a total of 20 imputations
using the multiple imputation method Markov chain
Monte Carlo (MCMC). Moreover, a non-responder ana-
lysis was performed by statistical comparison of partici-
pating GPs’ and average German GPs’ characteristics.
The study protocol was approved by the local ethics
committee (reference number: 4454–06/15) and we
report the results in the line with the STROBE
standards [31].
Results
220 GPs (22% of the 1000 contacted GPs) participated in
our survey. They were 54 years old on average, more
than half female, and they treated about 105 patients
with depression per quarter of a year (mean), 60% of
these with chronic depression (see Table 1).
Extensive missing data was recorded in only one partici-
pant who had to be excluded from the analysis. Over all
items of the questionnaire, the widest between imputation
variance observed was 3.7% (range from −1.9 to +1.8).
93% of the participating GPs stated that they distin-
guish patients with chronic depression from patients
with acute depressive episode (chi-square test; p < 0.01).
They reported to start AD treatment earlier (44%) and
to prescribe for longer time (69%) as well as to intensify
monitoring and follow-up (61%). 47% of GPs reported a
rather early referral to mental health care specialists.
Half of the GPs reported to use validated instruments
for diagnostic and/or monitoring purposes regularly.
92% would recommend psychotherapeutic co-treatment
to their chronically depressed patients. About 84% of
primary care patients with chronic depression are pre-
scribed ADs. If initiated, a guideline-concordant length
of AD prescription (≥ 24 weeks) would be applied in ap-
proximately 60% of the cases. Over 92% of GPs indicated
to provide weekly consultations during acute phase of
two months. Monitoring of blood count and liver en-
zymes (96%) as well as routine ECGs (89%) were stated
to be part and parcel of GPs’ care. 80% of GPs would
utilize switching of ADs in case of non-response without
a prior consultation of a specialist. 56% declared to
screen for psychiatric comorbidities, 56% reported that
they use psychoeducational methods, 59% adherence en-
hancement strategies and 50% develop crisis manage-
ment plans when dealing with chronically depressed
patients.
About 80% of participating GPs declared patient’s age
(75 years and older) as a relevant factor of clinical deci-
sion making: 90% rated severe physical comorbidity as
relevant, 97% comorbid anxiety disorder and 95% co-
morbid substance use disorder.
Most GPs favour a restraint on medication (52%) in
older patients with chronic depression but on the other
hand nearly 40% argue for long-term pharmacotherapy
(see Table 2). The presence of severe physical comorbid-
ity in patients with chronic depression leads GPs to ei-
ther holding back on ADs (65%) or urgent referrals to
mental health care specialists (40%). Long-term medica-
tion (13%), the necessity of psychotherapy (15%) or com-
bination therapy (20%) seem to be less important to
participating GPs. 66% of GPs see the need for combin-
ation therapy when comorbid anxiety disorder is coexist-
ent with chronic depression. 32% feel that psychotherapy
is essential. About 40% prefer an urgent referral to the
specialist. The factor comorbid substance abuse mainly
(84%) goes along with GP’s urgent referral. Only 12% of
GPs believe that an urgent referral to a mental health
care specialist is needed when their chronically de-
pressed patient is of high age. Psychotherapy alone (3%)
or a combination of pharmacotherapy and psychother-
apy (14%) play a subordinate role in GPs’ perceived
management of chronically depressed patients of ad-
vanced age.
No significant differences regarding the reported re-
sults (main and additional questions) could be obtained
when GPs were paired by age, gender, years of clinical
experience, practice location or by the number of pa-
tients treated per quarter. When stratified by practice
profile, GPs working in a practice cooperation reported
to carry out weekly consultations (Chi-square: 4.55;
double-sided significance: .033) and ECG-controls (Chi-
Table 1 Participating GPs’ characteristics
Total
N 220
Age in years, mean (SD) 54.4 (8.5)
Female, n (%) 120 (54.5)*
Clinical experience in years, mean (SD) 27.2 (9.3)
Qualification of psychosomatic basic
medical care, n (%)**
178 (80.9)
Location of GP’s practice: rather rural, n (%) 111 (50.5)
Profile of GP’s practice: single, n (%) 130 (59.1)*
Patients per quarter, mean (SD) 1048.4 (351.1)*
Number of patients per quarter treated for
depression, mean (SD)
104.8 (103.8)
Number of patients per quarter treated for
chronic depression, mean (SD)
60.0 (62.8)
*significant difference (p < .05) compared to overall average of German GPs
(due to specific characteristics of GPs from Thuringia)
**Additional qualification needed for monetary compensation of psychosocial
exploration, counseling, educational and motivational techniques. Established
in the 1990s the curriculum aims to improve quality of care and has become
mandatory for all vocational trainees who want to specialize in the discipline
of General Practice
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square: 9.28; double-sided significance: .002) more fre-
quently than their colleagues working single-handed.
GPs with the additional qualification of psychosomatic
basic medical care stated to perform monitoring of
blood count and liver enzymes (Chi-square: 5.29;
double-sided significance: .021) as well as routine ECGs
(Chi-square: 5.73; double-sided significance: .017) more
often that GPs without this qualification.
Discussion
We studied German GPs’ self-reported management of
patients with chronic depression. The vast majority of
the GPs differentiated between chronic and acute
episodic depression as recommended by several authors
[2, 3, 5, 9, 10, 26].
The 220 participating GPs consider chronic depression
as amenable to treatment and GPs’ reported interven-
tions are extensive. These findings correspond with the
implications of a systematic review from Michalak and
Lam [32] and a mixed-method approach by Fleury et al.
[30]. ECG controls and monitoring of blood count and
liver enzymes are generally performed by participating
GPs. This goes along with guideline recommendations
[11]. ADs are prescribed to 84% of the chronically de-
pressed patients. Vuorilehto et al. [33] report that 82%
of patients with major depressive disorder (MDD) or
partly remitted MDD are prescribed ADs but only half
started and adequately adhered to AD treatment. Partici-
pating GPs feel confident in switching ADs in case of
non-response without prior consultation of a specialist.
This seems remarkable, since it is not in the line with
guideline recommendations [11, 34]. In our study the
majority of chronically depressed primary care patients
would receive an AD medication ≥24 weeks [11–13]. It
is considerably higher (60%) compared to claims data
analyses (40%) [35, 36]. This contrast may be explained
by a tendency of claims data analyses to overestimate
the number of patients with chronic depression as a
consequence of a perpetuated administrative documen-
tation of diagnosis codes. Due to the small number of
studies investigating the effectiveness of psychothera-
peutic treatment among chronically depressed primary
care patients it remains unclear if the GP-reported per-
ceptions of the suitability of psychotherapeutic co-
treatment (92%) are based on solid evidence. The
reported numerous consultations, the frequent use of
validated instruments for diagnostic and/or monitoring
purposes as well as the reported effort to screen for psy-
chiatric comorbidity are in contrast to everyday experi-
ence [37] and might result from desirability and
willingness rather than actual implementation. Half of
the participating GPs reported to use psychoeducational
methods, adherence enhancement strategies and crisis
management plans. This finding is supported by rising
evidence for such “low intensity psychosocial interven-
tions” but so far the effectiveness related to chronically
depressed primary care patients has not been systematic-
ally investigated [11, 13, 38]. Nevertheless, relating to
low intensity psychosocial interventions NDMG high-
lights the coordinative role that GPs can play in the con-
text of multimorbidity and in order to prevent further
fragmentation of care [11]. Though, it has to be consid-
ered that a simple guideline implementation strategy
might be ineffective for improving the management of
depression in primary care settings [39–41]. A tailored
intervention (including outreach visits, web-based recom-
mendations and recourses, management tools) to imple-
ment guideline recommendations for elderly patients with
depression in primary care did in fact raise guideline ad-
herence of participating GPs but did not show relevant
differences between the intervention and control groups
in terms of depression severity, anxiety, loneliness, contact
with voluntary organisations, physical activity, utilisation
of self-help programmes and medication adherence [42].
It is argued that depression guideline recommendations
can be made more relevant and applicable for primary
care if they addressed the effectiveness of different treat-
ment options and focused on the integration of relevant
social factors, comorbidities as well as the patients’ indi-
vidual needs and preferences [25, 28, 43, 44].
The reported treatment of chronically depressed pa-
tients aged 75 years or more is heterogeneous. There
seem to be two lines of GPs managing the chronically
depressed elderly: Going along with the findings of Lin-
den and Kurtz [24], one line (about 50%) states that
older age implies a restraint in AD medication although
guideline recommendations have highlighted that ADs
are also effective in elderly patients with a stronger focus
on side effects and compatibility [11, 13]. The other line
(about 40%) holds that a systematic long-term medica-
tion is especially important in patients of advanced age
going along with NICE recommendations on elderly pa-
tients with multiple depressive episodes [13]. There is
only a small fraction of GPs (12%) believing that an ur-
gent referral to a mental health care specialist is needed
when their chronically depressed patient is of high age.
More generally expressed, psychotherapy seems to play a
subordinate role in GPs’ management of chronically de-
pressed patients of older age [24]. These findings go
along with results from claims data analyses presuming
that advanced age is a predictor for withholding psycho-
therapeutic interventions [36]. Clinically, the low rates
may result from difficulties for the provision of psycho-
therapy to older patients because of limited mobility,
somatic comorbidity or sensory disabilities [11].
The presence of a severe physical comorbidity (e.g.
heart failure, cancer, COPD) seems to have a strong ef-
fect (91%) on GPs’ treatment decisions in terms of an
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urgent referral to a psychiatric specialist. Concerning the
reported restraint in ADs in this patient group (52%) our
findings are in line with Coventry et al. [29]. Neverthe-
less, there are contradictory findings that chronic phys-
ical comorbidity does not consistently lead to lower
quality of depression treatment or follow-up care in de-
pressed primary care patients [29, 45].
Comorbid mental disorders are valued as highly rele-
vant. Substance use disorder is faced with urgent refer-
rals (84%) whereas anxiety disorder is mainly (66%) dealt
with by combined pharmacological and psychothera-
peutic treatment.
Piek et al. found that chronicity, suicidal tendency, the
perceived need for psychotherapy and the number of
ADs used induced GPs to refer depressive patients to
mental health care specialists [27]. However, the authors
proposed that other factors must play a part in GPs’ de-
cision for referral since only 8–11% of variance could be
explained. Our findings suggest that the presence of
patient-related factors such as severe physical comorbid-
ity and mental comorbidity might determine whether
GPs refer chronically depressed patients to mental
health care specialists.
Remarkably, GPs’ self-reported management showed
high consistency in subgroup analyses. This result sug-
gests that participating GPs’ perceptions and reported
therapeutic measures are independent from GPs’ charac-
teristics like their age, gender, clinical experience or lo-
cation of practice.
Limitations
The low response rate (22%) was in accordance with the
response to postal questionnaire surveys among GPs ob-
tained by Cottrell et al. [46]. From other studies we
know that non-responders are of higher age, more expe-
rienced, single handed, more stressed (measured by
number of patients per quarter) and less well qualified
than responding GPs [47]. The comparison of the char-
acteristics of the 220 GPs, who have participated in the
survey, with the basic population of German GPs, did
not show any deviations in the mentioned variables. The
main divergence between participating GPs and the
basic population of GPs in Germany is due to the spe-
cific distribution of GPs from Thuringia who represent
54% of our sample. GPs from Thuringia are rather fe-
male (62% vs. 42%), single handed (69% vs. 57.5%) and
treat more patients per quarter (1116.4 vs. 848.7) than
average German GPs. However, the mentioned charac-
teristics did not seem to influence GPs’ attitudes and re-
ported management when subgroup analyses were
carried out. To sum up, selection bias cannot fully be
excluded and may limit the results.
Another limitation of our study is a possible misclassi-
fication bias due to a non-validated questionnaire. But
between imputation variances showed no substantial or
systematic effect due to incomplete data. Since a case re-
port and a definition of chronic course have been pro-
vided, GPs’ responses might have been influenced by
this information.
We do not know if participating GPs used patients’ re-
cords and electronic administrative data while complet-
ing the questionnaire or if they simply based their
statements on estimation and intuition. Therefore, we
can neither exclude social desirability bias nor overesti-
mation respectively underestimation of GPs’ reported ac-
tions and perceptions.
Conclusion
GPs report high awareness towards chronic depression.
Advanced age, severe physical and mental comorbidity
seem to play an important role in GPs’ treatment deci-
sions in chronic depression care. Possibly, the GPs’ co-
ordinative role in counselling and performing low
intensity psychosocial interventions needs further ad-
vancement. Our findings may help to improve the man-
agement of chronic depression in primary care.
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